0001104659-21-152294.txt : 20211221
0001104659-21-152294.hdr.sgml : 20211221
20211221180342
ACCESSION NUMBER: 0001104659-21-152294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211218
FILED AS OF DATE: 20211221
DATE AS OF CHANGE: 20211221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carroll David Francis
CENTRAL INDEX KEY: 0001703623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 211510484
MAIL ADDRESS:
STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm2135829-7_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-18
0
0001410939
IVERIC bio, Inc.
ISEE
0001703623
Carroll David Francis
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK
NY
10001
0
1
0
0
SVP, CFO and Treasurer
Common Stock
2021-12-18
4
M
0
14375
A
111740
D
Common Stock
2021-12-20
4
S
0
6710
15.4435
D
105030
D
Restricted Stock Units
2021-12-18
4
M
0
14375
0
D
Common Stock
14375
43125
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 18, 2021.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker on December 20, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
On December 18, 2020, the Reporting Person was granted an award of 57,500 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.
/s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll
2021-12-21